Skip to main content

Advertisement

Log in

Placental Syncytiotrophoblast Maintains a Specific Type of Glycocalyx at the Fetomaternal Border: The Glycocalyx at the Fetomaternal Interface in Healthy Women and Patients With HELLP Syndrome

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Recent studies showed that considerable amounts of glycosaminoglycans are released into maternal blood during normal pregnancy and in hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Maternal endothelia and the syncytiotrophoblast layer have been discussed as a possible origin of these glycocalyx components. Our study aimed to visualize the glycocalyx on the syncytiotrophoblast by electron microscopy, to analyze its structure and composition by immunohistochemistry, and to determine potential differences between healthy women and women with HELLP syndrome. For electron microscopy, a cotyledon was fixed by perfusion of the intervillous space with a 2% lanthanum–nitrate glutaraldehyde solution followed by immersion fixation in the same fixative. For immunohistochemistry, sections of 16 placentas (HELLP patients/healthy women, n = 8 each) were stained with monoclonal antibodies against the main glycocalyx constituents syndecan 1, hyaluronic acid, and heparan sulfate. Semiquantitative evaluation of staining intensity focused on the apical surface of the syncytiotrophoblast and fetal intravillous endothelia as possible localizations of a placental glycocalyx. Electron microscopy revealed a glycocalyx of approximately 250 nm, covering the syncytiotrophoblast layer. This was found to contain large amounts of syndecan 1, but neither hyaluronic acid nor heparan sulfate as major components. Intravillous fetal endothelium did not express any of the investigated glycosaminoglycans. Healthy women and patients with HELLP showed no differences concerning glycocalyx composition and thickness of the syncytiotrophoblast. The composition of the “placental” glycocalyx differs from the adult and fetal vascular glycocalyx. Obviously, the human placental syncytiotrophoblast maintains a special kind of glycocalyx at the fetomaternal interface.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hofmann-Kiefer KF, Kemming GI, Chappell D, et al. Serum heparan sulfate levels are elevated in endotoxemia. Eur J Med Res. 2009;14(12):526–531.

    Article  CAS  Google Scholar 

  2. Platts SH, Linden J, Duling BR. Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. Am J Physiol Heart Circ Physiol. 2003;284(6):H2360–H2367.

    Article  CAS  Google Scholar 

  3. Gouverneur M, Berg B, Nieuwdorp M, Stroes E, Vink H. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J Intern Med. 2006;259(4):393–400.

    Article  CAS  Google Scholar 

  4. Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009; 104(1):78–89.

    Article  CAS  Google Scholar 

  5. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for plateletendothelial cell adhesion. Circulation. 2000;101(13):1500–1502.

    Article  CAS  Google Scholar 

  6. Crescimanno C, Marzioni D, Paradinas FJ, et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast 1. J Pathol. 1999;189(4):600–608.

    Article  CAS  Google Scholar 

  7. Lorenzi T, Turi A, Crescimanno C, et al. Syndecan expressions in the human amnion and chorionic plate. Eur J Histochem. 2010; 54(4):e42.

    Article  CAS  Google Scholar 

  8. Matejevic D, Neudeck H, Graf R, Muller T, Dietl J. Localization of hyaluronan with a hyaluronan-specific hyaluronic acid binding protein in the placenta in pre-eclampsia. Gynecol Obstet Invest. 2001;52(4):257–259.

    Article  CAS  Google Scholar 

  9. Chappell D, Jacob M, Paul JO, et al. The glycocalyx of the human umbilical vein endothelial cell—an impressive structure ex vivo, but not in culture. Circ Res. 2009;104(11):1013–1017.

    Article  Google Scholar 

  10. Barker AL, Konopatskaya O, Neal CR, et al. Observation and characterisation of the glycocalyx of viable human endothelial cells using confocal laser scanning microscopy. Phys Chem Chem Phys. 2004;6(5):1006–1011.

    Article  CAS  Google Scholar 

  11. Hofmann-Kiefer KF, Knabl J, Martinoff N, et al. Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study. Reprod Sci. 2013;20(3):318–325.

    Article  Google Scholar 

  12. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623–627.

    Article  CAS  Google Scholar 

  13. Martin JN Jr., Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180(6 pt 1):1373–1384.

    Article  Google Scholar 

  14. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8.

    Article  Google Scholar 

  15. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100(5):1211–1223.

    Article  CAS  Google Scholar 

  16. Klein M, Vignaud JM, Hennequin V, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):656–658.

    Article  CAS  Google Scholar 

  17. Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev. 1991;4(1):129–178.

    Article  CAS  Google Scholar 

  18. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79(3):581–589.

    Article  CAS  Google Scholar 

  19. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res. 2003;92(6): 592–594.

    Article  Google Scholar 

  20. Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc. 1966;25(6):1773–1783.

    CAS  PubMed  Google Scholar 

  21. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–167.

    Article  CAS  Google Scholar 

  22. Bachmaier N, Linnemann K, May K, et al. Ultrastructure of human placental tissue after 6 h of normoxic and hypoxic dual in vitro placental perfusion. Placenta. 2007;28(8–9):861–867.

    Article  CAS  Google Scholar 

  23. Haigh M, Chawner LE, Fox H. The human placenta does not contain lipofuscin pigment. Placenta. 1984;5(5):459–464.

    Article  CAS  Google Scholar 

  24. Eaton BM, Leach L, Firth JA. Permeability of the fetal villous microvasculature in the isolated perfused term human placenta. J Physiol. 1993;463:141–155.

    Article  CAS  Google Scholar 

  25. Chen CP, Liu SH, Lee MY, Chen YY. Heparan sulfate proteoglycans in the basement membranes of the human placenta and decidua. Placenta. 2008;29(4):309–316.

    Article  CAS  Google Scholar 

  26. Haimov-Kochman R, Friedmann Y, Prus D, et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod. 2002;8(6):566–573.

    Article  CAS  Google Scholar 

  27. Muhlhauser J, Marzioni D, Morroni M, Vuckovic M, Crescimanno C, Castellucci M. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta 2. Cell Tissue Res. 1996;285(1):101–107.

    Article  CAS  Google Scholar 

  28. Jokimaa V, Inki P, Kujari H, Hirvonen O, Ekholm E, Anttila L. Expression of syndecan-1 in human placenta and decidua. Placenta. 1998;19(2–3):157–163.

    Article  CAS  Google Scholar 

  29. Jokimaa VI, Kujari HP, Ekholm EM, Inki PL, Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia Am J Obstet Gynecol. 2000;183(6):1495–1498.

    Article  CAS  Google Scholar 

  30. Gao L, Lipowsky HH. Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes 1. Microvasc Res. 2010;80(3):394–401.

    Article  CAS  Google Scholar 

  31. Wasserman L, Abramovici A, Shlesinger H, Goldman JA, Allalouf D. Histochemical localization of acidic glycosaminoglycans in normal human placentae 1. Placenta. 1983;4(1):101–108.

    Article  CAS  Google Scholar 

  32. Steegers EA, von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–644.

    Article  Google Scholar 

  33. Gifford RW. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.

    Article  Google Scholar 

  34. van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy. 2008;27(3):253–265.

    Article  Google Scholar 

  35. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606): 75–84.

    Article  Google Scholar 

  36. Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG. 2006;113(suppl 3):17–42.

    Article  CAS  Google Scholar 

  37. Bernal A. Overview. Preterm labour: mechanisms and management. BMC Pregnancy Childbirth. 2007;7(suppl 1):S2.

    Article  Google Scholar 

  38. Norman JE. Preterm labour. Cervical function and prematurity. Best Pract Res Clin Obstet Gynaecol. 2007;21(5):791–806.

    Article  Google Scholar 

  39. Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol. 2009;23(6):765–777.

    Article  Google Scholar 

  40. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17): 1896–1906.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus F. Hofmann-Kiefer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hofmann-Kiefer, K.F., Chappell, D., Knabl, J. et al. Placental Syncytiotrophoblast Maintains a Specific Type of Glycocalyx at the Fetomaternal Border: The Glycocalyx at the Fetomaternal Interface in Healthy Women and Patients With HELLP Syndrome. Reprod. Sci. 20, 1237–1245 (2013). https://doi.org/10.1177/1933719113483011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719113483011

Keywords

Navigation